SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rob C. who wrote (16)11/14/1996 6:00:00 PM
From: Steve   of 370
 
Robert,

Thanks for the info on Yale's patent.
Although this is great news, the market has yet to acknowledge.
In otherwords, a buying opportunity. I believe the same antiviral agent may be effective against HIV as well!

This will help VION attract addtional capital and move it closer to having real products for sale (although FDA approval is a long way off).

What impresses me most about the company is the lineup of products in various stages of development. Assuming additional progress on VION's TAPET is made and announced, this is a 10-bagger.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News